BioSpace News Archive

Prothena to Participate in Stifel 2022 Virtual CNS Days

Prothena Corporation plc announced that members of its senior management team will participate in a fireside chat at the Stifel 2022 Virtual CNS Days on Monday March 28, 2022 at 12:30 PM ET.

March 21, 2022
·
1 min read
Business

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update

ORIC Pharmaceuticals, Inc. today announced the discontinuation of ORIC-101 and also reported financial results and operational updates for the quarter and year ended December 31, 2021.

March 21, 2022
·
13 min read
Policy

Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing Defect

Adamis Pharmaceuticals Corporation is voluntarily recalling certain lots of SYMJEPI Injection 0.15 mg and 0.3 mg Pre-Filled Single-Dose Syringes to the consumer level.

March 21, 2022
·
3 min read
Biotech Beach

Neurocrine Biosciences to Present at Stifel 2022 CNS Days

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Stifel 2022 CNS Days virtual conference at 3:30 p.m. Eastern Time on Monday, March 28, 2022.

March 21, 2022
·
1 min read
Business

MARPAI TO HOST FOURTH QUARTER & FULL YEAR 2021 FINANCIAL RESULTS CALL ON MARCH 31, 2022

Marpai, Inc. will host a conference call and webcast on Thursday, March 31 at 8:30 a.m. ET to answer questions about the Company’s operational and financial highlights for its fourth quarter.

March 21, 2022
·
1 min read
Business

Haemonetics Appoints James D’Arecca Chief Financial Officer

Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive Vice President, Chief Financial Officer, effective April 11, 2022.

March 21, 2022
·
2 min read
FDA

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients With MSI‑H/dMMR Advanced Endometrial Carcinoma

FDA Approves Merck’s KEYTRUDA ® (pembrolizumab) for Patients With MSI‑H/dMMR Advanced Endometrial Carcinoma, Who Have Disease Progression Following Prior Systemic Therapy in Any Setting and Are Not Candidates for Curative Surgery or Radiation.

March 21, 2022
·
68 min read
Advanced Proteome Therapeutics Announces Warrant Extension

The Warrants’ exercise price and original expiry date are detailed below. The Warrants expiry date is to be extended to September 30, 2022.

March 21, 2022
·
2 min read
ScreenPro Announces Growth in Covid Testing

Though the Covid environment is changing, testing is strong with a 50% increase in added productions compared to February and over 20% in weekly growth this month.

March 21, 2022
·
4 min read
General Surgery Devices Market to Hit US$ 2,051.23 Million by 2028

The general surgery devices market size is predicted to hit US$ 2,051.23 million by 2028 from valued at US$ 1,587.39 million in 2021 and growing at a CAGR of 3.8% from 2021 to 2030.

March 21, 2022
·
5 min read